Close

USANA Health Sciences (USNA) Tops Q4 EPS by 44c, Offers Guidance

February 9, 2021 4:20 PM EST

USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.87, $0.44 better than the analyst estimate of $1.43. Revenue for the quarter came in at $310.5 million versus the consensus estimate of $291.54 million.

GUIDANCE:

USANA Health Sciences sees FY2021 EPS of $6.00-$6.45, versus the consensus of $5.77. USANA Health Sciences sees FY2021 revenue of $1.21-1.27 billion, versus the consensus of $1.19 billion.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings